1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Pathological Myopia: new trials by email Literature Review of Pathological Myopia trials Research Report on Pathological Myopia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia Ranibizumab, Verteporfin PDT, Sham Ranibizumab - Pathological Myopia | Phase 3 | Completed | Novartis Pharmaceuticals | 277 | 2010-10-01 | 2014-02-10 |
Choroidal Neovascularization (1) · Myopia, Degenerative (1)
Choroid Diseases (1) · Eye Diseases (1) · Metaplasia (1) · Myopia (1) · Neovascularization, Pathologic (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Refractive Errors (1) · Uveal Diseases (1)
Ranibizumab (1)
Austria (1) · Canada (1) · France (1) · Germany (1) · Hong Kong (1) · Hungary (1) · India (1) · Italy (1) · Japan (1) · Latvia (1) · Lithuania (1) · Poland (1) · Portugal (1) · Singapore (1) · Slovakia (1)